Purdue To Pay $16M To Settle OxyContin Claims
Purdue Pharma LP has agreed to pay $16 million to settle claims by direct purchasers of OxyContin that the drugmaker filed bogus patent litigation to crush generic competition....To view the full article, register now.
Already a subscriber? Click here to view full article